A great deal of research is involved in bringing PARNUTs to the marketplace
. Research often begins with identifying an unfilled nutritional need, dete
rmining a that need is great enough to warrant development of a new product
, and then evaluating the efficacy and safety of the potential product in a
nimal models and clinical trials. This approach tends to emphasize short-te
rm outcomes, however, while neglecting the issues of whether a product offe
rs long term benefit or holds long term risks. This article presents discus
sion centered around the need for selecting appropriate outcomes far nutrit
ional intervention trials, designing trials with a follow-up rime sufficien
t to allow for outcome measurement, and enrolling a patient population larg
e enough to accurately gauge efficacy and tolerability.